The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: A secondary analysis of RTOG 9704

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 5, 2011, Pages 1328-1335

  Showalter, Timothy N ^a   Winter, Kathryn A ^b   Berger, Adam C ^a   Regine, William F ^c   Abrams, Ross A ^d   Safran, Howard ^e   Hoffman, John P ^f   Benson, Al B ^g   MacDonald, John S ^h   Willett, Christopher G ⁱ  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e Brown University Oncology Group   (United States)

^f FOX CHASE CANCER CENTER   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h ST VINCENT S COMPREHENSIVE CANCER CENTER   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Lymph node; Nodal ratio; Pancreatic cancer; Pancreaticoduodenectomy; Radiation therapy

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CHEMORADIATION; CONTEMPORARY TECHNIQUES; COOPERATIVE GROUPS; DISEASE-FREE SURVIVAL; KAPLAN-MEIER METHOD; LYMPH NODE; MIN-MAX; MULTI VARIATE ANALYSIS; NODAL RATIO; NODE-NEGATIVE; PANCREATIC CANCER; PANCREATIC CANCERS; PANCREATICODUODENECTOMY; PROPORTIONAL HAZARDS MODEL; RADIATION THERAPY ONCOLOGY GROUPS; SURGICAL RESECTION;

CHEMOTHERAPY; DISEASE CONTROL; DISEASES; MULTIVARIANT ANALYSIS; RADIATION HAZARDS; RADIOTHERAPY; SURGERY;

BODY FLUIDS;

FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; LYMPH NODE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHEMORADIOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 81855166242     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.07.1993     Document Type: Article

References (41)

1. A. Jemal, R. Siegal, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. M. Garofalo, T. Flannery, and W. Regine The case for adjuvant chemoradiation for pancreatic cancer Best Pract Res Clin Gastroenterol 20 2006 403 416
3. M.C. Garofalo, W.F. Regine, and M.T. Tan On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer Ann Surg 244 2006 332 333 (Pubitemid 44305560)
4. Gastrointestinal Tumor Study Group Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection for pancreatic cancer Cancer 59 1987 2006 2010
5. M.H. Kalser, and S.S. Ellenberg Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 1985 899 903 (Pubitemid 15040883)
6. J.H. Klinkenbijl, H. Jeekel, and T. Sahmoud Adjuvant radiotherapy and 5-fluoruracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group Ann Surg 230 1999 776 784 (Pubitemid 30191812)
7. J.P. Neoptolemos, D.D. Stocken, and H. Friess A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200 1210 (Pubitemid 38339364)
8. M.L. Foo, L.L. Gunderson, and D.M. Nagorney Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil Int J Radiat Oncol Biol Phys 26 1993 483 489 (Pubitemid 23182344)
9. S. Hishinuma, Y. Ogata, and M. Tomikawa Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings J Gastrointest Surg 10 2006 511 518 (Pubitemid 43619152)
10. C.J. Yeo, R.A. Abrams, and L.B. Grochow Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Ann Surg 225 1997 621 633
11. J.M. Herman, M.J. Swartz, and C.C. Hsu Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital J Clin Oncol 26 2008 3503 3510
12. L. Hazard, J.D. Tward, and A. Szabo Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: Results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry data Cancer 110 2007 2191 2201 (Pubitemid 350100740)
13. J.E. Lim, M.W. Chien, and C.C. Earle Prognostic factors following curative resection for pancreatic adenocarcinoma: A population-based, linked database analysis of 396 patients Ann Surg 237 2003 74 85 (Pubitemid 36622320)
14. W.F. Regine, K. Winter, and R.A. Abrams Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial JAMA 299 2008 1019 1026 (Pubitemid 351347058)
15. T.A. Sohn, C.J. Yeo, and J.L. Cameron Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 2000 567 579
16. S.P. Cleary, R. Gryfe, and M. Guindi Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivors J Am Coll Surg 198 2004 722 731 (Pubitemid 38542900)
17. R.A. Smith, L. Bosonnet, and P. Ghaneh Preoperative CA 19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma Dig Surg 25 2008 226 232
18. A.C. Berger, M. Garcia Jr., and J.P. Hoffman Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704 J Clin Oncol 26 2008 5918 5922
19. M.G. House, M. Gonen, and W.R. Jarnagin Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer J Gastrointest Surg 11 2007 1549 1555
20. R.E. Schwarz, and D.D. Smith Extent of lymph node retrieval and pancreatic cancer survival: Information from a large US population database Ann Surg Oncol 13 2006 1189 1200 (Pubitemid 44440420)
21. M.B. Slidell, D.C. Chang, and J.L. Cameron Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: A large, population-based analysis Ann Surg Oncol 15 2008 165 174
22. M. Hellan, C.-L. Sun, and A. Artinyan The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer Pancreas 37 2008 19 24
23. T.M. Pawlik, A.L. Gleisner, and J.L. Cameron Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer Surgery 141 2007 610 618 (Pubitemid 46616937)
24. A.C. Berger, J.C. Watson, and E.A. Ross The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma Am Surg 70 2004 235 240
25. M. Falconi, S. Crippa, and I. Dominguez Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma Ann Surg Oncol 15 2008 3178 3186
26. M.G. Hurtuk, C. Hughes, and M. Shoup Does lymph node ratio impact survival in resected periampullary malignancies? Am J Surg 197 2009 348 352
27. C. Mariette, G. Piessen, and N. Briez The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg 247 2008 365 371 (Pubitemid 351156783)
28. A.C. Berger, E.R. Sigurdson, and T. LeVoyer Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes J Clin Oncol 23 2005 8706 8712 (Pubitemid 46211514)
29. Abrams RA, Winter KA, Regine WF, et al. RTOG 9704-Radiotherapy Quality Assurance (QA) Review and Survival. American Society for Radiation Oncology Annual Meeting. Philadelphia, PA; 2006.
30. J.S. Tomlinson, S. Jain, and D.J. Bentrem Accuracy of staging node-negative pancreas cancer: A potential quality measure Arch Surg 142 2007 767 774
31. C.W. Michalski, J. Kleeff, and M.N. Wente Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer Br J Surg 94 2007 265 273 (Pubitemid 46423842)
32. S. Pedrazzoli, V. DiCarlo, and R. Dionigi Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study Ann Surg 228 1998 508 517 (Pubitemid 30194394)
33. S.K. Reddy, D.S. Tyler, and T.N. Pappas Extended resection for pancreatic adenocarcinoma Oncologist 12 2007 654 663 (Pubitemid 47036202)
34. M.B. Farnell, G.V. Aranha, and Y. Nimura The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence J Gastrointest Surg 12 2008 651 656
35. M. Glanemann, B. Shi, and F. Liang Surgical strategies for treatment of malignant pancreatic tumors: Extended, standard or local surgery? World J Surg Oncol 6 2008 123
36. C.A. Staley, K.R. Cleary, and J.L. Abbruzzese The need for standardized pathologic staging of pancreaticoduodenectomy specimens Pancreas 12 2006 373 380
37. N.V. Adsay, O. Basturk, and D. Altinel The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: Comparison of conventional vs orange-peeling approach in pathologic assessment Mod Pathol 22 2009 107 112
38. B.C.H. van der Wal, R.M.J.M. Butzelaar, and S. van der Meij Axillary lymph node ratio and total number of removed lymph nodes: Predictors of survival in stage I and II breast cancer EJSO 28 2002 481
39. N.K. Altorki, X.K. Zhou, and B. Stiles Total number of resected lymph nodes predicts survival in esophageal cancer Ann Surg 248 2008 221 226
40. A.J. Greenstein, V.R. Litle, and S.J. Swanson Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer Cancer 112 2008 1239 1246 (Pubitemid 351429738)
41. K. Inoue, Y. Nakane, and H. Iiyama The superiority of ratio-based lymph node staging in gastric carcinoma Ann Surg Oncol 9 2002 27 34 (Pubitemid 34262894)